| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 30 | 23 | 30 | 36 | 40 | 51 | 0 |
| Expenses | 30 | 22 | 27 | 28 | 32 | 41 | 0 |
| EBITDA | 0 | 0 | 3 | 8 | 9 | 10 | 0 |
| Operating Profit % | 1 % | 1 % | 10 % | 22 % | 21 % | 20 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 3 | 7 | 8 | 10 | 0 |
| Tax | 0 | 0 | 1 | 2 | 2 | 2 | 0 |
| Net Profit | 0 | 0 | 2 | 5 | 6 | 7 | 0 |
| EPS in ₹ | 1.77 | 0.88 | 42.54 | 6.72 | 5.36 | 6.26 | 0.00 |
Shelter Pharma
Shelter Pharma
44.57
-44.57
(-100.00%)
There are 2 new updates from the company21 hours ago
View
Market Cap
51.50 Cr
EPS
6.26
PE Ratio
7.12
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
69.70
52 Week Low
35.70
PB Ratio
1.23
Debt to Equity
0.02
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Shelter Pharma Limited has installed a 15 KW solar power plant at its factory in Himmatnagar, Gujarat, as part of its sustainability initiative. The solar panels are positioned on the factory roof to harness renewable energy for manufacturing operations. The company projects the solar plant will have a 25-year lifespan and expects to recover installation costs through energy savings within four years, leading to electricity cost savings for the subsequent 21 years. The installation represents a step in Shelter's move towards sustainable and eco-friendly manufacturing practices.
Shelter Pharma Secures $124,050 Order from Sudan-Based Taha Drugs & ChemicalsAug 25, 2025
Shelter Pharma Limited has secured an order worth $124,050 from Taha Drugs & Chemicals Co. Ltd, an international entity based in Sudan. The order covers Joemega Capsule and All Vitamins tablet products and is to be executed within 2 months. The contract is structured as a fixed cost arrangement. The company confirmed that promoters and group companies have no interest in the entity awarding the order, and the transaction does not fall under related party transactions. Shelter Pharma Limited describes itself as a pharmaceutical and nutraceutical company focused on research, innovation, and quality healthcare solutions.
Shelter Pharma Limited announced that 14 of its veterinary products have been selected for supply to Gujarat Co-operative Milk Marketing Federation Ltd. (AMUL). The company stated this development marks a significant step forward in its growth in the animal healthcare sector and demonstrates its commitment to delivering high-quality Ayurvedic welfare solutions for the dairy industry. The selection is expected to positively contribute to the company's business prospects in the animal healthcare segment.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,636.20 | #1 3,82,526.00 | 34.22 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 43.29 | |
5,710.00 | 1,51,038.30 | 65.74 | 9,712.00 | 18.67 | 2,191 | 26.74 | 28.97 | |
3,567.10 | 1,21,948.70 | 59.71 | 11,539.40 | 6.99 | 1,911 | 19.91 | 51.91 | |
1,513.00 | 1,21,429.70 | 22.68 | 28,409.50 | 7.12 | 5,291 | 9.88 | 39.80 | |
1,244.70 | 1,02,131.70 | #1 18.31 | 33,741.20 | 16.73 | 5,725 | 1.26 | 34.86 | |
2,439.60 | 1,00,535.60 | 53.25 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 34.79 | |
991.15 | 98,802.10 | 21.41 | 23,511.00 | 18.55 | 4,615 | 2.60 | 40.31 | |
1,981.30 | 87,299.50 | 24.47 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 38.96 | |
5,459.50 | 64,864.00 | 28.71 | 13,458.30 | 3.70 | 2,216 | 21.39 | 52.88 | |
1,086.00 | 62,953.10 | 18.78 | 32,345.60 | 9.43 | 3,484 | -10.24 | 49.39 |
Forecast
Actual
Growth Rate
Revenue Growth
26.75 %
Net Income Growth
16.13 %
Cash Flow Change
379.59 %
ROE
-2.14 %
ROCE
-1.88 %
EBITDA Margin (Avg.)
-7.19 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 11 | 10 | 13 | 21 | 38 | 48 |
| Fixed Assets | 2 | 2 | 2 | 2 | 4 | 6 |
| Current Assets | 8 | 8 | 10 | 19 | 30 | 33 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 9 | 9 | 11 | 20 | 34 | 42 |
| Total Liabilities | 11 | 10 | 13 | 21 | 38 | 48 |
| Current Liabilities | 4 | 3 | 4 | 6 | 2 | 5 |
| Non Current Liabilities | 0 | 0 | 0 | 1 | 1 | 1 |
| Total Equity | 7 | 7 | 9 | 15 | 36 | 43 |
| Reserve & Surplus | 7 | 7 | 8 | 7 | 24 | 31 |
| Share Capital | 1 | 1 | 1 | 8 | 12 | 12 |
Cash Flow
| Cash Flow | 2017 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 | 0 | 5 | -2 |
| Investing Activities | 0 | 0 | 0 | -1 | 0 | -4 | -7 |
| Operating Activities | 0 | -0 | -0 | 1 | 0 | -2 | 6 |
| Financing Activities | 0 | 0 | 1 | 0 | 0 | 11 | 0 |
Share Holding
| % Holding | Aug 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Aug 2025 |
| Promoter | 56.89 % | 56.89 % | 56.89 % | 54.97 % | 52.32 % | 52.32 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.22 % | 30.18 % | 30.23 % | 40.12 % | 43.24 % | 42.69 % |
| Others | 13.89 % | 12.93 % | 12.88 % | 4.91 % | 4.44 % | 4.99 % |
| No of Share Holders | 1,165 | 836 | 868 | 1,119 | 1,153 | 1,109 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Sept 2024 |  Dividend | ₹ 0.33 /share | 23 Sept 2024 | 46.97 | 48.21 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 46.97 | 47.50 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 46.88 | 47.15 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 38.00 | 39.50 |
| 23 Jul 2025 |  Extraordinary General Meeting | NA | 23 Jul 2025 | 39.60 | 43.97 |
| 23 Sept 2025 | Dividend | ₹ 0.35 /share | 23 Sept 2025 | 45.00 | 43.27 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 45.00 | 44.00 |
Announcements
Announcement under Regulation 30 (LODR)-Conversion of Securities
21 hours ago
21 hours agoBoard Meeting Outcome for Equity Shares Allotted Pursuant To Conversion Of Fully Paid Warrants.21 hours ago
21 hours agoShareholder Meeting / Postal Ballot-Scrutinizers Report1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Change in Management1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Change in Management1 day ago
1 day agoShareholder Meeting / Postal Ballot-Outcome of AGM1 day ago
1 day agoClosure of Trading Window2 days ago
2 days agoIntimation Of Shelter PharmaS Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing Regulations9 days ago
9 days agoShelter Pharma Limited Embarks On Sustainability Journey With The Installation Of A 15 KW Solar Power Plant At Its Factory Situated At Shelter Nagar Nr. S. T. Bus Stand Himmatnagar Gujarat India 38300110 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Sep 08, 2025Notice Of 18Th Annual General MeetingSep 06, 2025
Sep 06, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 02, 2025
Sep 02, 2025Approved Tuesday 23Rd September 2025 As The Cut-Off Date As For The Purpose Of E-Voting And Dividend Entitlement. Dividend Shall Be Payable To Equity Shareholder; Whose Names Stand Registered On The CompanyS Register Of
Members As Beneficial Owners As ASep 02, 2025
Sep 02, 2025To Close The Register Of Members Of The Company From Wednesday 24Th September 2025 To Tuesday 30Th September 2025 (Both Days Inclusive) For The Purpose Of Payment Of Dividend And Annual General Meeting.Sep 02, 2025
Sep 02, 2025The 18Th Annual General Meeting Of The Company Will Be Held On Tuesday 30Th September 2025 At 10:00 A.M. At Registered Office Of The Company At Shelter Nagar Nr. S. T. Bus Stand Himmatnagar GJ 383001 IN Gujarat For The Financial Year Ended On 31St March 2Sep 02, 2025
Sep 02, 2025Corporate Action-Board approves DividendSep 02, 2025
Sep 02, 2025Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday 02Nd
September 2025Sep 02, 2025
Sep 02, 2025Board Meeting Intimation for Intimation Regarding Meeting Of The Board Of Directors Of The Company That Will Be Held On Tuesday 02Nd September 2025.Aug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 20, 2025
Aug 20, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Selection Of Veterinary Products For Supply To AMULAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-AllotmentAug 06, 2025
Aug 06, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 06Th August 2025 For Allotment Of 8808000 WarrantsAug 06, 2025
Aug 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 24, 2025
Jul 24, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMJul 23, 2025
Jul 23, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 12, 2025
Jul 12, 2025Intimation Of Shelter PharmaS Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing RegulationsJul 04, 2025
Jul 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2025
Jul 01, 2025Submission Of Notice Of 01/2025-26 Extra-Ordinary General Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 30, 2025
Jun 30, 2025Convening Of 01/2025-26 Extra-Ordinary General Meeting (EGM) On Wednesday 23Rd July 2025 At 10:00 A.M At The Registered Office Of The Company. The Notice Of The Said EGM And Other Related Details Shall Be Submitted To The Stock Exchanges In Due Course In Jun 26, 2025
Jun 26, 2025Fixed Thursday 17Th July 2025 As The Record Date For The Purpose Of Determining The Eligibility Of The Members To Attend And Vote (Including Through E-Voting) At The 01/2025-26 Extraordinary General Meeting (EGM) Of The Company Scheduled To Be Held On WedJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Preferential IssueJun 26, 2025
Jun 26, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today On Thursday 26Th June 2025 And Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015Jun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Board Meeting Intimation for Fund RaisingJun 23, 2025
Jun 23, 2025Announcement under Regulation 30 (LODR)-Raising of FundsJun 18, 2025
Jun 18, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today On Wednesday 18Th June 2025 And Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.Jun 18, 2025
Jun 18, 2025Closure of Trading WindowJun 14, 2025
Jun 14, 2025Board Meeting Intimation for Intimation Of Board Meeting Pursuant To The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).Jun 14, 2025
Jun 14, 2025Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations 2015 For The Half Year And Year Ended March 2025.May 29, 2025
May 29, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 Regarding Appointment Of CA Ismail Ibrahimbhai Lakhani (M/S. I I LAKHANI & CO) FRN NO: 143750W Chartered Accountants As Internal AuditorMay 29, 2025
May 29, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 Regarding Reappointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor For The Period Of 5 YearsMay 29, 2025
May 29, 2025Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31 2025May 29, 2025
May 29, 2025Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31 2025May 29, 2025
May 29, 2025Board Meeting Intimation for Audited Financial Results For The Half Year Ended And Year Ended On March 31 2025May 24, 2025
May 24, 2025Announcement Regulation 30 Read With Schedule III Part A Para B Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2025
May 05, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 10, 2025
Apr 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Technical Indicators
RSI(14)
Neutral 49.93
ATR(14)
Volatile 1.36
STOCH(9,6)
Neutral 65.91
STOCH RSI(14)
Neutral 53.34
MACD(12,26)
Bearish -0.07
ADX(14)
Weak Trend 21.01
UO(9)
Bearish 71.03
ROC(12)
Downtrend And Accelerating -1.24
WillR(14)
Neutral -47.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
